CC BY 4.0 · TH Open 2022; 06(01): e21-e25
DOI: 10.1055/a-1709-5441
DOI: 10.1055/a-1709-5441
Letter to the Editor
Daily Monitoring of D-Dimer Allows Outcomes Prediction in COVID-19
Autoren
-
1 Innovative Therapies in Hemostasis, University of Paris, Paris, France2 Hematology Department and Biosurgical Research Lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, Paris, France
-
Olivier M. Bory
3 Emergency Department, AP-HP, Georges Pompidou European Hospital, Paris, France -
Jean-Luc Diehl
1 Innovative Therapies in Hemostasis, University of Paris, Paris, France4 Intensive Care Unit and Biosurgical Research Lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, Paris, France -
Alexis Mareau
5 Medical Informatics, Biostatistics and Public Health Department, Centre de Recherche des Cordeliers, AP-HP, University of Paris, Georges Pompidou European Hospital, European Georges Pompidou Hospital, Paris, France -
1 Innovative Therapies in Hemostasis, University of Paris, Paris, France2 Hematology Department and Biosurgical Research Lab (Carpentier Foundation), AP-HP, Georges Pompidou European Hospital, Paris, France
-
Anne-Sophie Jannot
5 Medical Informatics, Biostatistics and Public Health Department, Centre de Recherche des Cordeliers, AP-HP, University of Paris, Georges Pompidou European Hospital, European Georges Pompidou Hospital, Paris, France -
Richard Chocron
6 Emergency Department, University of Paris, PARCC, Georges Pompidou European Hospital, Paris, France
